Lukas Martin MD, MHBA

Lukas Martin is a Co-Founder and Chief Executive Officer at the Clinomic Group, a holding company that combines state-of-the-art research with modern technologies and rethinks critical care medicine. Lukas Martin graduated in Medicine and Health Business Administration and received with honors the Venia legendi in Anesthesiology and Intensive Care Medicine at RWTH Aachen University. Lukas Martin is a consultant and group leader at the Department of Intensive and Intermediate Care at the University Hospital RWTH Aachen and an honorary senior visiting lecturer at Queen Mary University, School of Medicine and Dentistry, London. Lukas Martin's expertise lies in translational medicine combining basic and clinical research with data-driven methods and artificial intelligence. Lukas Martin's projects are supported by several funding organizations including the German Research Foundation (DFG), the Federal Ministry of Education and Research (BMBF), and the European Institute for Innovation & Technology (EIT Health), a body of the European Union in the framework of HORIZON 2020. Lukas Martin's work was recognized by multiple national and international awards including the Karl-Thomas prize and the Fresenius fellowship of the German Society of Anesthesia and Intensive Care Medicine (DGAI) as well as the inaugural Chaudry award of the American Shock Society.